ADHD Slows Speech in Poor Hearing: Evidence from Eye Movements

Published Date: 02 Mar 2023

A new study by Prof. Boaz Ben-David and Rony Lemel of Reichman University's Baruch Ivcher School of Psychology has found that attention deficit hyperactivity disorder (ADHD) causes slow and difficult understanding of words.

Read Full News

Latest News

Hormone Therapy and Thrombosis: What Clinicians May Miss?

Route of administration, patient history, and formulation choice may shape thrombotic risk more than clinicians previously recognized.

When Does a Tick Bite Need Antibiotics?

The guidance varies depending on the tick and whether it is in endemic area for illnesses like Lyme disease.

Liver & Colorectal Conditions: How New Data Will Impact Care

In this DDW 2026 update, Dr David Johnson reviews key advances in cirrhosis care, GLP-1 benefits, earlier HCC detection, colorectal cancer risks, and IL-23-targeted IBD therapies.

Stool Metabolites May Predict Crohn’s Complications

Fecal metabolomic profiling in Crohn’s disease reveals distinct metabolite patterns linked to disease activity, location, and complication risk.

Specific Risk Factors Make Difficult-to-Treat RA More Likely

Researchers conducted a meta-analysis of 21 studies to find lifestyle factors and comorbidities that raise odds for having difficult-to-treat rheumatoid arthritis.

Stress and Neighborhood Support Affect Sleep Among Teens

Feeling more stressed is linked to irregular sleep patterns and problems in teens, whereas living in a supportive neighborhood is linked to steadier sleep patterns.

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Todays Updates

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Too Many Chest CTs for Incidental Lung Nodules?

Across 273 requests for chest CTs for incidental lung findings on neck imaging, only one indolent lung cancer was detected.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

The approval of IV atezolizumab and atezolizumab with hyaluronidase-tqjs is the first for bladder cancer since a 2022 withdrawal of accelerated approval of atezolizumab for urothelial carcinoma.

Latest News

Route of administration, patient history, and formulation choice may shape thrombotic risk more than clinicians previously recognized.

The guidance varies depending on the tick and whether it is in endemic area for illnesses like Lyme disease.

In this DDW 2026 update, Dr David Johnson reviews key advances in cirrhosis care, GLP-1 benefits, earlier HCC detection, colorectal cancer risks, and IL-23-targeted IBD therapies.

Fecal metabolomic profiling in Crohn’s disease reveals distinct metabolite patterns linked to disease activity, location, and complication risk.

Researchers conducted a meta-analysis of 21 studies to find lifestyle factors and comorbidities that raise odds for having difficult-to-treat rheumatoid arthritis.

Feeling more stressed is linked to irregular sleep patterns and problems in teens, whereas living in a supportive neighborhood is linked to steadier sleep patterns.

News All Time

Free Birth Movement Presents Ethical Quandary: Ethicist

Art Caplan discusses the medical ethics involved in a free birth that went terribly wrong.

Obesity Management After Unsuccessful Dieting

A 45-year-old woman with a BMI of 38 kg/m2 presents with obesity despite lifestyle modifications. This case discussion on obesity highlights management strategies with novel incretin-based therapies.

The Ivermectin Paradox in Oncology

Dr Arturo Loaiza-Bonilla examines the gap between ivermectin’s lab data and clinical reality, offering a guide to debunking ‘miracle cure’ myths while maintaining patient trust.

TikTok and the Squatty Potty: Seeking Help for Constipation

Two studies take different approaches to improving constipation, one examining the influence of TikTok and the other examining the effect of physical positioning.

Peptides Lack Reliable Safety Information, Watchdog Warns

As peptides for wellness surge in popularity, two safety groups warn many users may be injecting unapproved substances with little evidence they are safe or effective.

Adjunctive Antipsychotics for Major Depression Ranked

A new meta-analysis shows meaningful differences among FDA-approved antipsychotic adjuncts for MDD, with lumateperone showing the strongest efficacy and aripiprazole the best overall acceptability.

Exoskeletons Set the Pace in Amyotrophic Lateral Sclerosis

The new exoskeleton technology combines biomechanics, sensors, and patient feedback to support gait training and rehabilitation in amyotrophic lateral sclerosis.

FDA Expands Vyvgart Approval to All Adults With gMG

The label expansion will include adults with AChR-Ab-negative gMG, making efgartigimod the first and only approved treatment for all serotypes of the rare neuromuscular disease.

Caring for the Carers: The NHS's Blind Spot

Millions of unpaid carers are damaging their own health — and slipping through the cracks of a system that should catch them.

Cholangitis: 1 Day of Antibiotics Noninferior to 4-7 Days

Compared with the recommended 4- to 7-day antibiotic course, a 1-day regimen achieved similar clinical cure rates, with no differences in mortality or other outcomes.

IgA Nephropathy: Advances Drive a Wave of New Therapies

New understanding about the pathophysiology of the condition, along with new clinical trial endpoints for approval, have resulted in a flood of new treatments.

Recurrent UTIs Within 6 Months May Signal Cancer Risk

Individuals presenting with repeated UTIs experience longer diagnostic delays and poorer outcomes than those presenting with hematuria.

Acute Liver Failure: 5 Things to Know

Acute liver failure requires rapid recognition and intervention, with delays associated with significantly increased mortality risk.

What’s Really Going on in Aging Tendons and Ligaments

Staying active your whole life means avoiding injury. Connective tissue may not get the same love muscles do but these strategies can mitigate risk.

New Data: US Psilocybin Use Reaches 8 Million

About 8 million people in the US use psilocybin, which is linked to depression, alcohol use disorder, cannabis use, and prescription drug misuse, a new study shows.

Genotype-Guided SSRI Prescribing Offers Mixed Results

Use of genotype-guided SSRI shows no symptom improvement at 3 months in people with depression but is linked to higher remission rates at 6 months.

Recommended News For You

Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant

Interleukin-6 may boost prediction of obesity-related cancers

Brain cancer: a Q&A session.

Global warming could be driving up women's cancer risk, find researchers

Toxic fungus from King Tutankhamun's tomb yields cancer-fighting compounds—new study

Researchers Challenge USPSTF's Lung Cancer Screening Criteria

Telemedicine services linked to reducing excess mortality

Recommended Articles For You

The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management 

Unveiling the Complexity of Multiple Myeloma Staging 

New Research on Craniopharyngioma  

Precision Oncology: Cancer Screening, Genetic Counseling & Hereditary Cancer Syndromes Integration 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

2.

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

3.

Alone for 500 Days, but Never Lonely: The Introvert's Dream.

4.

Millions of men could benefit from faster scan to diagnose prostate cancer

5.

Team finds broken 'brake' on cancer mutation machine.

1.

Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics

2.

Unravelling the Mysteries of Monoclonal Gammopathy

3.

Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment

4.

Landmark Medical Oncology Trials Redefining Early Breast Cancer Management

5.

The Statistical Frontier of Hematology Oncology: Diagnostics, Therapies, and Future Horizons in Hematology Oncology 2025

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

2.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

3.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

5.

Oropharyngeal Cancer in Relation to HPV Status

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot